Expanding Discovery in Cardiovascular Genome-Wide Association Studies

Pradeep Natarajan; Elizabeth M. McNally

doi:10.1001/jamacardio.2021.1635

Expanding Discovery in Cardiovascular Genome-Wide Association Studies

Pradeep Natarajan^*, Elizabeth M. McNally

^*Corresponding author for this work

Medicine, Cardiology Division

Research output: Contribution to journal › Comment/debate › peer-review

1 Scopus citations

Original language	English (US)
Pages (from-to)	1012
Number of pages	1
Journal	JAMA cardiology
Volume	6
Issue number	9
DOIs	https://doi.org/10.1001/jamacardio.2021.1635
State	Published - Sep 2021

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

Access to Document

10.1001/jamacardio.2021.1635

Cite this

@article{07807f3aab8f4862b803e37a0e4cb3f3,

title = "Expanding Discovery in Cardiovascular Genome-Wide Association Studies",

author = "Pradeep Natarajan and McNally, {Elizabeth M.}",

note = "Funding Information: reported receiving grants from Amgen, Apple, Boston Scientific, and AstraZeneca; personal fees from Apple, Blackstone Life Sciences, Novartis, Genentech/Roche, AstraZeneca, and Foresite Labs; and spousal employment at Vertex outside the submitted work. Dr McNally reported receiving grants from the National Institutes of Health to Northwestern University and from the American Heart Association to Northwestern University during the conduct of the study and personal fees from Amgen, Avidity, AstraZeneca, Cytokinetics, 4D Molecular Therapeutics, Pfizer, Janssen, Tenaya, and Invitae outside the submitted work and is the founder of Ikaika Therapeutics, which is unrelated to the content of manuscript. No other disclosures were reported.",

year = "2021",

month = sep,

doi = "10.1001/jamacardio.2021.1635",

language = "English (US)",

volume = "6",

pages = "1012",

journal = "JAMA Cardiology",

issn = "2380-6583",

publisher = "American Medical Association",

number = "9",

}

TY - JOUR

T1 - Expanding Discovery in Cardiovascular Genome-Wide Association Studies

AU - Natarajan, Pradeep

AU - McNally, Elizabeth M.

N1 - Funding Information: reported receiving grants from Amgen, Apple, Boston Scientific, and AstraZeneca; personal fees from Apple, Blackstone Life Sciences, Novartis, Genentech/Roche, AstraZeneca, and Foresite Labs; and spousal employment at Vertex outside the submitted work. Dr McNally reported receiving grants from the National Institutes of Health to Northwestern University and from the American Heart Association to Northwestern University during the conduct of the study and personal fees from Amgen, Avidity, AstraZeneca, Cytokinetics, 4D Molecular Therapeutics, Pfizer, Janssen, Tenaya, and Invitae outside the submitted work and is the founder of Ikaika Therapeutics, which is unrelated to the content of manuscript. No other disclosures were reported.

PY - 2021/9

Y1 - 2021/9

UR - http://www.scopus.com/inward/record.url?scp=85108119179&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85108119179&partnerID=8YFLogxK

U2 - 10.1001/jamacardio.2021.1635

DO - 10.1001/jamacardio.2021.1635

M3 - Comment/debate

C2 - 34106205

AN - SCOPUS:85108119179

SN - 2380-6583

VL - 6

SP - 1012

JO - JAMA Cardiology

JF - JAMA Cardiology

IS - 9

ER -

Expanding Discovery in Cardiovascular Genome-Wide Association Studies

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this